Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-30T01:25:40.820Z Has data issue: false hasContentIssue false

The onset of pipecuronium following application of the priming principle

Published online by Cambridge University Press:  04 August 2006

F. K. Pühringer
Affiliation:
Clinics for Anaesthesia and General Intensive Care Medicine, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
G. Mitterschiffthaler
Affiliation:
Clinics for Anaesthesia and General Intensive Care Medicine, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
K. S. Khuenl-Brady
Affiliation:
Clinics for Anaesthesia and General Intensive Care Medicine, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
H. J. Sparr
Affiliation:
Clinics for Anaesthesia and General Intensive Care Medicine, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
A. Benzer
Affiliation:
Clinics for Anaesthesia and General Intensive Care Medicine, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
Get access

Abstract

Pipecuronium bromide, a long acting non-depolarizing neuromuscular blocking agent was administered to four groups of 10 patients using the priming technique.The effects of the combination of two different priming doses (0.01 or 0.015 mg kg−1) given at two different time intervals (3 or 4 min) before the ‘main’ intubating dose (0.07 or 0.065 mg kg−1) were investigated. Onset times were recorded and the intubation conditions were scored and compared with a group of patients receiving the same total amount of pipecuronium(0.08 mg kg−1) in a single bolus injection. Intubating conditions at 90 s after administration of the intubating dose were found to be significantly improved in all primed groups but the onset times, evaluated using the response of the adductor pollicis muscle to a single twitch stimulation, were similar to that observed after the single bolus injection. The optimal priming combination is considered to be 0.01 mg kg−1 of pipecuronium followed 3 to 4 min later by 0.07 mg kg−1.

Type
Original Article
Copyright
1996 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)